# An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

> **NCT00696436** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 1291 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Azilsartan medoxomil
- **DRUG:** Azilsartan medoxomil
- **DRUG:** Valsartan
- **DRUG:** Olmesartan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00696436
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 1291 (ACTUAL)
- **Last updated:** 2011-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696436, "An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00696436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*